2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine

2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine Struktur
381714-28-9
CAS-Nr.
381714-28-9
Englisch Name:
2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine
Synonyma:
2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine;8H-Cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine, 2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-
CBNumber:
CB62073291
Summenformel:
C21H22N4OS
Molgewicht:
378.49
MOL-Datei:
381714-28-9.mol

2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine Eigenschaften

Dichte
1.39±0.1 g/cm3(Predicted)
pka
0.34±0.20(Predicted)

Sicherheit

2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine Chemische Eigenschaften,Einsatz,Produktion Methoden

2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6350 50
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6178 60
Specs --
info@specs.net The Netherlands 6835 70

  • 2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-8H-cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine
  • 8H-Cyclohepta[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine, 2-[(2,6-dimethylphenoxy)methyl]-9,10,11,12-tetrahydro-
  • 381714-28-9
Copyright 2019 © ChemicalBook. All rights reserved